ancillary_id,nct_id,drug1,drug2,ancillary_notes
anaipd001,NCT01778049,metformin,empagliflozin,Population A Empagliflozin 25mg. Empagliflozin was introduced during open label phase at START of trial which precedes double-blind phase
anaipd002,NCT01778049,metformin,empagliflozin,Population B Empagliflozin 10mg. Empagliflozin was introduced during open label phase at START of trial which precedes double-blind phase
